| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8425602 | Stem Cell Research | 2018 | 4 Pages |
Abstract
An induced pluripotent stem cell (iPSC) line was generated from a 36-year-old patient with sporadic Parkinson's disease (PD). Skin fibroblasts were reprogrammed using the non-integrating Sendai virus technology to deliver OCT3/4, SOX2, c-MYC and KLF4 factors. The generated cell line (CSC-43) exhibits expression of common pluripotency markers, in vitro differentiation into three germ layers and normal karyotype. This iPSC line can be used to study the mechanisms underlying the development of PD.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biotechnology
Authors
Ana Marote, Yuriy Pomeshchik, Stefano Goldwurm, Anna Collin, Nuno J. Lamas, LuÃsa Pinto, António J. Salgado, Laurent Roybon,